Detalhe da pesquisa
1.
IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation.
Immunity;
54(11): 2531-2546.e5, 2021 11 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34644537
2.
ß2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression.
Immunity;
54(8): 1772-1787.e9, 2021 08 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34289378
3.
The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts.
Immunity;
54(5): 1002-1021.e10, 2021 05 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33761330
4.
Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids.
Nature;
629(8010): 184-192, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38600378
5.
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours.
Nature;
618(7967): 1033-1040, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37316667
6.
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
N Engl J Med;
390(8): 687-700, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38381673
7.
CAR T-cell therapy in autoimmune diseases.
Lancet;
402(10416): 2034-2044, 2023 11 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37748491
8.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood;
140(4): 349-358, 2022 07 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35316325
9.
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry.
Cell Commun Signal;
22(1): 186, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38509561
10.
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
Eur J Haematol;
112(4): 641-649, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38164819
11.
CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas.
Eur Radiol;
34(2): 790-796, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37178198
12.
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib.
Cancer Immunol Immunother;
72(6): 1661-1672, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36602564
13.
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.
Blood;
138(19): 1830-1842, 2021 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34289026
14.
CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma.
Blood;
138(24): 2499-2513, 2021 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34166502
15.
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
BMC Cancer;
23(1): 1153, 2023 Nov 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38012567
16.
Anticancer Aminoferrocene Derivatives Inducing Production of Mitochondrial Reactive Oxygen Species.
Chemistry;
28(30): e202104420, 2022 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35419888
17.
N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells.
Stem Cells;
38(8): 986-993, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32346937
18.
PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis.
Cell Mol Life Sci;
76(23): 4783-4794, 2019 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31168659
19.
CD19-targeted CAR T cells in refractory antisynthetase syndrome.
Lancet;
401(10379): 815-818, 2023 03 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36930673
20.
More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
N Engl J Med;
385(19): e67, 2021 11 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34731551